1. A new deletion of 18q23 with few typical features of the 18q- syndrome. Issue 3 (March 1996) Authors: Kohonen-Corish, M; Strathdee, G; Overhauser, J; McDonald, T; Jammu, V Journal: Journal of medical genetics Issue: Volume 33:Issue 3(1996) Page Start: 240 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. OP03 Anti-SARS-CoV2 antibody responses are attenuated in patients with Inflammatory Bowel Disease treated with infliximab. (27th May 2021) Authors: Kennedy, N A; Goodhand, J; Bewshea, C; Nice, R; Chee, D; Lin, S; Chanchlani, N; Butterworth, J; Cooney, R; Croft, N; Hart, A; Irving, P; Kok, K; Lamb, C; Limdi, J; MacDonald, J; McGovern, D; Mehta, S; Murray, C; Patel, K Journal: Journal of Crohn's and colitis Issue: Volume 15(2021)Supplement 1 Page Start: S002 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. P181 Patient-led remote intracapillary pharmacokinetic sampling (fingerPRICKS) for therapeutic drug monitoring in patients with Inflammatory Bowel Disease. (27th May 2021) Authors: Chee, D; Nice, R; Hamilton, B; Jones, E; Hawkins, S; Redstone, C; Cairnes, V; Pohl, K; Chanchlani, N; Lin, S; Kennedy, N; Ahmad, T; Goodhand, J; McDonald, T Journal: Journal of Crohn's and colitis Issue: Volume 15(2021)Supplement 1 Page Start: S252 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Islet Autoantibody Standardization Program 2018 Workshop: Interlaboratory Comparison of Glutamic Acid Decarboxylase Autoantibody Assay Performance. (1st September 2019) Authors: Lampasona, Vito; Pittman, David L; Williams, Alistair J; Achenbach, Peter; Schlosser, Michael; Akolkar, Beena; Winter, William E; Watson, K; Weets, I; Tao, Y; Chen, V; Yang, Y; Uibo, R; Reimand, K; Knip, M; Härkönen, T; Chatenoud, L; Achenbach, P; Neidhoefer, S; Schlosser, M Journal: Clinical chemistry Issue: Volume 65:Number 9(2019) Page Start: 1141 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. OP24 Neutralising antibody potency against SARS-CoV-2 wild-type and Omicron BA.1 and BA.4/5 variants in infliximab and vedolizumab treated patients with Inflammatory Bowel Disease after three doses of COVID-19 vaccine: a prospective multicentre cohort study. (30th January 2023) Authors: Liu, Z; Le, K; Zhou, X; Alexander, J; Lin, S; Bewshea, C; Chanchlani, N; Nice, R; McDonald, T; Lamb, C; Sebastian, S; Kok, K; Lees, C; Hart, A; Pollok, R; Boyton, R; Altmann, D; Pollock, K; Goodhand, J; Kennedy, N Journal: Journal of Crohn's and colitis Issue: Volume 17(2023)Supplement 1 Page Start: i32 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗